Skip to main content

Dalfampridine and Fatigue: What Users Say

Brand names: Ampyra

Fatigue: mentioned by 3 users (3.6%)

Based on user experiences from 83 Dalfampridine reviews, the following table shows the most commonly mentioned side effects.

All user comments are moderated by Drugs.com. Each review is verified for relevance and screened for inappropriate content. Side effects are user-reported and not clinically verified.

dizziness 10.8%
constipation 4.8%
back pain 3.6%
fatigue 3.6%
seizures 3.6%

Reviews for Dalfampridine

Commonly mentioned side effects
  • Jim...
  • Taken for less than 1 month
  • June 10, 2013

For Multiple Sclerosis "Was having increasing difficulty with my left leg (drop foot, dragging, fatigue especially when on hills) and my left arm (typing characters out of order, weakness). Yes, I have Multiple Sclerosis. Took my first dose 3 days ago. Began to feel improvement within two doses, but thought it was a placebo effect. By the next day, I was walking hills with ease, only muscle soreness (after) and a bit winded (during), but none of the neurological issues! I could also feel the medicine's effect beginning to diminish about the 10th hour after a dose."

10 / 10
Was this helpful?YesNo
121 Report
  • Lha...
  • Taken for 2 to 5 years
  • June 9, 2012

For Multiple Sclerosis "I still use a scooter. But, I've had MS for almost 40 years. I am able to do physical therapy and stand. I have much greater energy and a significant lessening of my horrible fatigue, with improved bowel function. The effect leaves soon after the end of the dosage period. My husband loves how it has improved the quality of both our lives."

8 / 10
Was this helpful?YesNo
79 Report
  • Dit...
  • Taken for 5 to 10 years
  • August 29, 2016

For Multiple Sclerosis "20+ years of RR without awareness/disability. When it changed to SD with dizziness, poor balance, many falls, intense fatigue, foot drop, diminished walking, muscle spasms, bladder & bowel issues, MRIs confirmed without argument. I participated in a Canadian study of 'Fampyra' with measurements of ability before and after administration. Improvements were marked, and I certainly couldn't deny the disease. Progression is manageable. When 'Fampyra' was approved for use by Health Canada, I continued on it. My insurer does not cover it. I'm so grateful to be able to continue. The neurologist remains satisfied, and so am I. It's not a cure. Comments from other users encourage physiotherapy to 'keep and improve the ability I have'. Thanks, I needed that!"

10 / 10
Was this helpful?YesNo
47 Report

Are you taking this medicine?

Your review helps others make informed decisions.
Write a review
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.